Related Experiment Video
Updated: Apr 28, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Belgian consensus on metabolic problems associated with atypical antipsychotics
A De Nayer1, M De Hert, A Scheen
1Hôpital Sainte-Thérèse, Montignie sur Sambre, Belgium.
Abstract:
A workshop was convened by a panel of psychiatrists, diabetologists and pharmacists from major Belgian hospitals to review the latest information relating to the risks with second-generation antipsychotics (SGA) for the development of metabolic disorders, especially impaired glucose tolerance, diabetes mellitus and dyslipidemia. The panelists sought to formulate recommendations for practising psychiatrists when initiating and maintaining therapy with SGA, and for the switch of SGA or initiation of further treatment if metabolic complications occur. In addition, recommendations for counselling of the patient and for the cooperation between the psychiatrist and the general physician or diabetologist, respectively, were provided.
More Related Videos
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents
Antidepressant Drugs: MAOIs and Other Agents
Mania and Antimanic Drugs: Overview

